EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

specific

A diffuse large B-cell lymphoma originally described in patients older than 50 years, but it has been increasingly recognized in younger patients. Epstein-Barr virus is present in all cases. There is no known history of immunodeficiency or prior lymphoma.

55

Centers

60

Active Trials

Cancer Funding

Top Centers for EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified(55)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.7
2
NCI Comprehensive
Active Research Program
69.7
3
NCI Comprehensive
Active Research Program
69.7
4
NCI Comprehensive
Active Research Program
69.7
5
NCI Comprehensive
Active Research Program
69.7
6
NCI Comprehensive
Active Research Program
69.7
7
NCI Comprehensive
Active Research Program
69.7
8
Active Research Program
69.7
9
Active Research Program
69.7
10
NCI Comprehensive
Active Research Program
48.9
11
NCI Comprehensive
Active Research Program
48.9
12
NCI Comprehensive
Active Research Program
48.9
13
NCI Comprehensive
Active Research Program
48.9
14
NCI Comprehensive
Active Research Program
48.9
15
NCI Comprehensive
Active Research Program
48.9
16
NCI Comprehensive
Active Research Program
48.9
17
NCI Comprehensive
Active Research Program
48.9
18
NCI Comprehensive
Active Research Program
48.9
1948.9
20
NCI Comprehensive
Active Research Program
48.9
21
NCI Comprehensive
Active Research Program
48.9
22
NCI Comprehensive
Active Research Program
48.9
23
NCI Comprehensive
Active Research Program
48.9
24
NCI Comprehensive
Active Research Program
48.9
25
NCI Comprehensive
Active Research Program
48.9
26
NCI Comprehensive
Active Research Program
48.9
27
NCI Clinical
Active Research Program
48.9
28
Active Research Program
48.9
29
NCI Comprehensive
Active Research Program
48.9
30
Active Research Program
48.9
31
NCI Comprehensive
Active Research Program
48.9
32
NCI Comprehensive
Active Research Program
48.9
33
NCI Clinical
Active Research Program
48.9
34
NCI Comprehensive
Active Research Program
48.9
35
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
48.9
36
NCI Clinical
Active Research Program
48.9
37
NCI Comprehensive
Active Research Program
48.9
38
Active Research Program
48.9
39
Active Research Program
48.9
40
NCI Basic_laboratory
Active Research Program
48.9
41
Active Research Program
48.9
42
Active Research Program
48.9
43
Active Research Program
48.9
44
Active Research Program
48.9
45
Active Research Program
48.9
46
Active Research Program
48.9
47
Active Research Program
48.9
48
Active Research Program
48.9
49
Active Research Program
48.9
50
Active Research Program
48.9
51
Active Research Program
48.9
52
NCI Comprehensive
30.0
53
NCI Comprehensive
30.0
54
NCI Comprehensive
30.0
55
Cedars-Sinai CancerLos Angeles, CA
30.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →